HR
VXRT

Howe & Rusling’s Vaxart VXRT Stock Holding History

Howe & Rusling’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7
Closed – – 1031
2021
Q1 		$0 Hold
7
– – ﹤0.01% 1025
2020
Q4 		$0 Buy
+7
New +$45 ﹤0.01% 1008

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Howe & Rusling's VXRT Position: Q2 2021 in Review

Howe & Rusling sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 7 shares.

Howe & Rusling first reported a position in VXRT in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

  • Howe & Rusling reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
  • Howe & Rusling sold 7 Vaxart shares in Q2 2021.
  • Howe & Rusling first reported a position in Vaxart in Q4 2020 and held it in 2 quarters.
  • Howe & Rusling's Vaxart position peaked at $0 in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Howe & Rusling's 13F filing for Q2 2021, filed 13 Aug 2021.